vimarsana.com

Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Analysts at HC Wainwright increased their FY2024 earnings estimates for shares of Unity Biotechnology in a research report issued on Tuesday, April 16th. HC Wainwright analyst M. Caufield now expects that the company will earn ($2.42) per share for the year, up from their previous estimate of […]

Related Keywords

,Commonwealth Equity Services ,Schonfeld Strategic Advisors ,Virtu Financial ,Unity Biotechnology Inc ,Nasdaq ,Unity Biotechnology ,Free Report ,Sigma Investments ,Street Group ,Strategic Advisors ,Equity Services ,Get Free Report ,Unity Biotechnology Daily ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.